| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = -$215,085 ) |
| | 2023 | 2017 | GENVEC, INC. | 910 CLOPPER RD STE 220N | GAITHERSBURG | MD | 20878-1353 | MONTGOMERY | USA | R41TR001869 | In Vivo Editing for Hemophilia Gene Therapy | 000 | 1 | NIH | 10/1/2022 | -$215,085 |
|
| Issue Date FY: 2018 ( Subtotal = -$3,840 ) |
| | 2018 | 2013 | GENVEC, INC. | 910 CLOPPER RD STE 220N | GAITHERSBURG | MD | 20878-1353 | MONTGOMERY | USA | R43AI100467 | Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development | 000 | 2 | NIH | 9/30/2018 | -$3,840 |
|
| Issue Date FY: 2017 ( Subtotal = $215,085 ) |
| | 2017 | 2017 | GENVEC, INC. | 910 CLOPPER RD STE 220N | GAITHERSBURG | MD | 20878-1353 | MONTGOMERY | USA | R41TR001869 | In Vivo Editing for Hemophilia Gene Therapy | 000 | 1 | NIH | 5/5/2017 | $215,085 |
|
| Issue Date FY: 2015 ( Subtotal = $0 ) |
| | 2015 | 2013 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI100467 | Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development | 001 | 2 | NIH | 3/23/2015 | $0 |
| | 2015 | 2013 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI100467 | Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development | 000 | 2 | NIH | 11/5/2014 | $0 |
|
| Issue Date FY: 2013 ( Subtotal = $589,058 ) |
| | 2013 | 2013 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI092917 | ADENOVIRUS-VECTORED RSV VACCINE NOT INHIBITED BY MATERNAL IMMUNITY | 000 | 2 | NIH | 5/9/2013 | $289,058 |
| | 2013 | 2013 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI100467 | Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development | 000 | 2 | NIH | 3/20/2013 | $300,000 |
|
| Issue Date FY: 2012 ( Subtotal = $600,000 ) |
| | 2012 | 2012 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI092917 | ADENOVIRUS-VECTORED RSV VACCINE NOT INHIBITED BY MATERNAL IMMUNITY | 000 | 1 | NIH | 4/30/2012 | $300,000 |
| | 2012 | 2012 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI100467 | Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development | 001 | 1 | NIH | 8/8/2012 | $300,000 |
| | 2012 | 2012 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI100467 | Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development | 001 | 1 | NIH | 8/8/2012 | -$300,000 |
| | 2012 | 2012 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI100467 | Pre-erythrocytic Stage Antigen Discovery for Malaria Vaccine Development | 000 | 1 | NIH | 3/20/2012 | $300,000 |
| | 2012 | 2010 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI084269 | HIGH THROUGHPUT GENOMICS SCREENING FOR MALARIA ANTIGEN DISCOVERY | 000 | 2 | NIH | 4/16/2012 | $0 |
|
| Issue Date FY: 2011 ( Subtotal = $899,329 ) |
| | 2011 | 2011 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R44AI063819 | PRODUCTION OF ADENOVECTOR BASED VACCINES | 000 | 5 | NIH | 7/18/2011 | $899,329 |
| | 2011 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43DC010291 | DEVELOPMENT OF NOVEL ALTERNATIVE SEROTYPE ADENOVIRAL VECTORS FOR GENE DELIVERY IN | 000 | 1 | NIH | 1/27/2011 | $0 |
| | 2011 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R21EY017608 | NOVEL REGULATION OF THE ANTI-ANGIOGENIC ACTIVITY OF PEDF BY PRO-ANGIOGENIC MMPS | 000 | 2 | NIH | 6/6/2011 | $0 |
| | 2011 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI077309 | NOVEL AD5 MALARIA VACCINE THAT CIRCUMVENTS PRE-EXISTING AD5 IMMUNITY | 000 | 2 | NIH | 3/9/2011 | $0 |
| | 2011 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43CA139641 | LOCAL THERAPY-A NOVEL APPROACH TO CANCER METASTASES | 000 | 1 | NIH | 8/30/2011 | $0 |
|
| Issue Date FY: 2010 ( Subtotal = $1,441,271 ) |
| | 2010 | 2010 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R44AI063819 | PRODUCTION OF ADENOVECTOR BASED VACCINES | 001 | 4 | NIH | 7/22/2010 | $886,735 |
| | 2010 | 2010 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI082771 | DEVELOPMENT OF AN AD14 VACCINE | 000 | 2 | NIH | 3/15/2010 | $254,536 |
| | 2010 | 2010 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI084269 | HIGH THROUGHPUT GENOMICS SCREENING FOR MALARIA ANTIGEN DISCOVERY | 000 | 2 | NIH | 7/5/2010 | $300,000 |
| | 2010 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R44AI063819 | PRODUCTION OF ADENOVECTOR BASED VACCINES | 000 | 3 | NIH | 7/15/2010 | $0 |
| | 2010 | 2005 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R44EY014769 | DEVELOPMENT OF PEDF PROTEIN: AN ANTIANGIOGENIC AGENT | 000 | 3 | NIH | 3/12/2010 | $0 |
|
| Issue Date FY: 2009 ( Subtotal = $2,800,089 ) |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI077147 | PRECLINICAL TESTING OF AN ADENOVIRAL VECTOR BASED HSV-2 VACCINE | 000 | 2 | NIH | 2/24/2009 | $300,000 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI077147 | PRECLINICAL TESTING OF AN ADENOVIRAL VECTOR BASED HSV-2 VACCINE | 001 | 2 | NIH | 6/16/2009 | $0 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43DC010291 | DEVELOPMENT OF NOVEL ALTERNATIVE SEROTYPE ADENOVIRAL VECTORS FOR GENE DELIVERY IN | 001 | 1 | NIH | 8/28/2009 | $9,074 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI075686 | ADENOVIRUS VECTORS FOR RESPIRATORY SYNCYTIAL VIRUS VACCINATION | 000 | 2 | NIH | 3/24/2009 | $300,000 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R21EY017608 | NOVEL REGULATION OF THE ANTI-ANGIOGENIC ACTIVITY OF PEDF BY PRO-ANGIOGENIC MMPS | 000 | 2 | NIH | 6/19/2009 | $235,066 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI082771 | DEVELOPMENT OF AN AD14 VACCINE | 001 | 1 | NIH | 4/27/2009 | $0 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI082771 | DEVELOPMENT OF AN AD14 VACCINE | 002 | 1 | NIH | 5/1/2009 | $0 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI077309 | NOVEL AD5 MALARIA VACCINE THAT CIRCUMVENTS PRE-EXISTING AD5 IMMUNITY | 000 | 2 | NIH | 3/6/2009 | $299,660 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI084269 | HIGH THROUGHPUT GENOMICS SCREENING FOR MALARIA ANTIGEN DISCOVERY | 000 | 1 | NIH | 7/14/2009 | $300,000 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43CA139641 | LOCAL THERAPY-A NOVEL APPROACH TO CANCER METASTASES | 000 | 1 | NIH | 9/28/2009 | $295,991 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R44AI063819 | PRODUCTION OF ADENOVECTOR BASED VACCINES | 000 | 3 | NIH | 8/14/2009 | $684,896 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43DC010291 | DEVELOPMENT OF NOVEL ALTERNATIVE SEROTYPE ADENOVIRAL VECTORS FOR GENE DELIVERY IN | 000 | 1 | NIH | 8/10/2009 | $129,625 |
| | 2009 | 2009 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878-4021 | MONTGOMERY | USA | R43AI082771 | DEVELOPMENT OF AN AD14 VACCINE | 000 | 1 | NIH | 3/26/2009 | $245,777 |
| | 2009 | 2007 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43EY018455 | ALTERNATE ADENOVECTOR IN EYE GIVES LONGER EXPRESSION | 000 | 1 | NIH | 8/4/2009 | $0 |
|
| Issue Date FY: 2008 ( Subtotal = $1,211,253 ) |
| | 2008 | 2008 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI077309 | NOVEL AD5 MALARIA VACCINE THAT CIRCUMVENTS PRE-EXISTING AD5 IMMUNITY | 000 | 1 | NIH | 3/31/2008 | $299,889 |
| | 2008 | 2008 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI075686 | ADENOVIRUS VECTORS FOR RESPIRATORY SYNCYTIAL VIRUS VACCINATION | 000 | 1 | NIH | 5/6/2008 | $300,000 |
| | 2008 | 2008 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R21EY017608 | NOVEL REGULATION OF THE ANTI-ANGIOGENIC ACTIVITY OF PEDF BY PRO-ANGIOGENIC MMPS | 000 | 1 | NIH | 5/19/2008 | $311,364 |
| | 2008 | 2008 | GENVEC INC | 65 WEST WATKINS MILL ROAD | GAITHERSBURG | MD | 20878 | MONTGOMERY | USA | R43AI077147 | PRECLINICAL TESTING OF AN ADENOVIRAL VECTOR BASED HSV-2 VACCINE | 000 | 1 | NIH | 2/20/2008 | $300,000 |
|
|
